Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate.
Ken Junyang GohHui Zhong ChaiThun How OngDuu Wen SewaGhee Chee PhuaQiao Li TanPublished in: Journal of intensive care (2020)
While validation studies are required, the ROX-HR index appears to be a promising tool for early identification of treatment failure in patients initiated on HFNC for acute hypoxemic respiratory failure or as a preventative treatment after a planned extubation.
Keyphrases
- respiratory failure
- heart rate
- extracorporeal membrane oxygenation
- mechanical ventilation
- heart rate variability
- end stage renal disease
- blood pressure
- acute respiratory distress syndrome
- newly diagnosed
- chronic kidney disease
- ejection fraction
- stem cells
- obstructive sleep apnea
- metabolic syndrome
- combination therapy
- bone marrow
- cell therapy
- insulin resistance
- prognostic factors
- replacement therapy
- hepatitis b virus
- acute kidney injury
- bioinformatics analysis
- positive airway pressure